Sample result
GLP-1, a diabetes hormone
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
The search
- Query
- GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
- Search
- Protein → Patent proteins · Automatic (Smith-Waterman)
- Set
- Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 5,000 sequences, 3,061 publications, 1,851 families
Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.
Patents
3,061 publications in 1,851 families match these filters.
-
US 11446253-B22022-09-20
Ionic liquids for internal delivery
PRESIDENT AND FELLOWS OF HARVARD COLLEGE and THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 11446398-B22022-09-20
Regulated biocircuit systems
OBSIDIAN THERAPEUTICS, INC.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 12831 of 31 identical, no gaps.
-
US 11447535-B22022-09-20
GLP-1 analogues
Sun Pharmaceutical Industries Limited
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 11453711-B22022-09-27
Fusion proteins of GLP-1 and GDF15 and conjugates thereof
BEIJING QL BIOPHARMACEUTICAL CO., LTD.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020220140443-A2022-10-18
A composition comprising a glucagon derivative for preventing or treating chronic kidney disease
HANMI PHARM. CO., LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020220140746-A2022-10-18
OPHTHALMIC PHARMACEUTICAL COMPOSITION AND USE THEREOF
FERRER INTERNACIONAL, S.A
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220140746-A2022-10-18
- JP 2023517459-A2023-04-26
- JP 2026041726-A2026-03-10
-
JP 2022544882-A2022-10-21
COMPOSITIONS AND PARTICLES FOR PAYLOAD DELIVERY
APPLIED MOLECULAR TRANSPORT INC
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 78 to 108. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 78 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 10831 of 31 identical, no gaps.
Family of 2
Grouped by a shared priority claim, US 62/887933.
- JP 2022544882-A2022-10-21
- JP 2025157475-A2025-10-15
-
KR 1020220143923-A2022-10-25
GLP-1R AND GCGR AGONISTS, FORMULATIONS, AND METHODS OF USE
SPITFIRE PHARMA, LLC
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220143923-A2022-10-25
- JP 2023514992-A2023-04-12
-
US 11485766-B22022-11-01
GLP-1 analogues
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 11510990-B22022-11-29
Conjugates of fusion proteins of GLP-1 and FGF21
BEIJING QL BIOPHARMACEUTICAL CO., LTD.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 11529394-B22022-12-20
Polypeptide conjugates and methods of uses
BEIJING QL BIOPHARMACEUTICAL CO., LTD.
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- US 11529394-B22022-12-20
- KR 1020230083294-A2023-06-09
- JP 2023545684-A2023-10-31
-
JP 2023503899-A2023-02-01
IONIC LIQUIDS FOR DRUG DELIVERY
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by a shared priority claim, US 62/939088.
- JP 2023503899-A2023-02-01
- JP 2026021383-A2026-02-10
-
JP 2023504494-A2023-02-03
STABLE LIQUID FORMULATIONS COMPRISING A GLUCAGON-LIKE PEPTIDE 1 AND USES THEREOF
ROSE PHARMA LLC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020230019499-A2023-02-08
CO-AGONISTS OF THE GLP-1 AND AMYLIN RECEPTORS
NOVO NORDISK A/S
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230019499-A2023-02-08
- KR 1020240074867-A2024-05-28
- US 12054528-B22024-08-06
-
KR 1020230022949-A2023-02-16
GLP1R AGONIST NMDAR ANTAGONIST CONJUGATES
KOBENHAVNS UNIVERSITET
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2023510206-A2023-03-13
INSULIN DERIVATIVE
GAN AND LEE PHARMACEUTICALS CO LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2023510218-A2023-03-13
LONG-ACTING GLP-1 COMPOUNDS
GAN AND LEE PHARMACEUTICALS CO LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2023510219-A2023-03-13
INSULIN DERIVATIVE
GAN AND LEE PHARMACEUTICALS CO LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2023510523-A2023-03-14
GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF CHRONIC KIDNEY DIESEASE AND DIABETIC KIDNEY DISEASE IN TYPE 2 DIABETES
MEDIMMUNE LIMITED
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2023510609-A2023-03-14
COMBINATIONAL THERAPY COMPRISING GLP-1 AND/OR GLP-1 ANALOGS, AND INSULIN AND/OR INSULIN ANALOGS
SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020230054419-A2023-04-24
VIRAL VECTOR ENCODING GLP-1 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING METABOLIC DISEASES IN FELINES
The Trustees of the University of Pennsylvania
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020230054671-A2023-04-25
COMPOSITIONS AND METHODS RELATED TO ACTIVATABLE THERAPEUTIC AGENTS
Amunix Pharmaceuticals, Inc
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3731 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230054671-A2023-04-25
- JP 2023535022-A2023-08-15
- JP 2026090244-A2026-06-02
-
US 11634455-B22023-04-25
Amino diacids containing peptide modifiers
CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A.
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 11634455-B22023-04-25
- US 12441760-B22025-10-14
-
JP 2023518645-A2023-05-08
DOSING REGIMEN OF GLP-1
SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020230074151-A2023-05-26
METHODS AND COMPOSITIONS RELATING TO GLP1R VARIANTS
TWIST BIOSCIENCE CORPORATION
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230074151-A2023-05-26
- JP 2023539245-A2023-09-13
-
JP 2023525467-A2023-06-16
INCRETIN ANALOGUE, PREPARATION METHOD THEREFOR, AND USE THEREOF
ZHEJIANG DOER BIOLOGICS CO LTD, Zhejiang Heze Pharmaceutical Technology Co Ltd
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4198059-A12023-06-21
MODULATION OF CELLULAR STRESS
UNIV QUEENSLAND
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2023528921-A2023-07-06
GLP-1 conjugate
University of Copenhagen
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020230104118-A2023-07-07
GLP-1 PRODRUGS AND USES HEREOF
NOVO NORDISK A/S
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230104118-A2023-07-07
- JP 2023534770-A2023-08-10
-
JP 2023100722-A2023-07-19
NOVEL POLYPEPTIDES WITH IMPROVED PROTEOLYTIC STABILITY, AND METHODS OF PREPARING AND USING SAME
TUFTS UNIVERSITY
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2023100722-A2023-07-19
- JP 2025120243-A2025-08-15
-
KR 1020230112568-A2023-07-27
PRODRUGS AND USES THEREOF
NOVO NORDISK A/S
Query Match 100.0%Identity 100.0%Family of 5
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 5
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230112568-A2023-07-27
- JP 2023106355-A2023-08-01
- KR 1020230159805-A2023-11-22
- US 11840560-B22023-12-12
- JP 2024015148-A2024-02-01
-
KR 1020230125802-A2023-08-29
NOVEL COMPOUNDS
IP2IPO INNOVATIONS LIMITED
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020230126712-A2023-08-30
LONG-ACTING GLUCAGON DERIVATIVE
ZHEJIANG DOER BIOLOGICS CO., LTD.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020230127297-A2023-08-31
HUMAN GLP-1 POLYPEPTIDE VARIANT AND USE THEREOF
SUZHOU ALPHAMAB CO., LTD
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230127297-A2023-08-31
- JP 2024507321-A2024-02-19
-
US 11752173-B22023-09-12
FGF21 and GLP1 double gene-modified mesenchymal stem cell and use in treating a metabolic disease
Beijing Jiyuan Biological Technology Co., Ltd.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 11753455-B22023-09-12
Compounds for treatment of obesity
Novo Nordisk A/S
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020230137342-A2023-10-04
HALF-LIFE EXTENDING MOIETIES AND METHODS OF USING THE SAME
Eli Lilly and Company
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230137342-A2023-10-04
- JP 2024506145-A2024-02-09
-
JP 2023550594-A2023-12-04
GLP-1, GIP and glucagon receptor triple agonists
Novo Nordisk A/S
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2023551050-A2023-12-06
POLYPEPTIDE CONTAINING DISULFIDE BONDS AND CAPABLE OF INHIBITING ACTIVITY OF SERINE PROTEASE, DERIVED HYBRID PEPTIDE THEREOF, AND USE THEREOF
INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
EP 4288461-A12023-12-13
FUSION POLYPEPTIDES FOR METABOLIC DISORDERS
BEIJING QL BIOPHARMACEUTICAL CO LTD
Query Match 100.0%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- EP 4288461-A12023-12-13
- KR 1020240034235-A2024-03-13
- JP 2024527613-A2024-07-25
- US 12331093-B22025-06-17
-
JP 2023552500-A2023-12-15
LONG-ACTING GLUCAGON DERIVATIVE
ZHEJIANG DOER BIOLOGICS CO LTD, ZHEJIANG HEZE PHARMACEUTICAL TECHNOLOGY CO LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
KR 1020230171471-A2023-12-20
GLUCAGON LIKE PEPTIDE COMPOUNDS
Novartis AG
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230171471-A2023-12-20
- JP 2024514352-A2024-04-01
-
US 11858975-B22024-01-02
Multi-domain active protein for treating metabolic diseases
ZHEJIANG DOER BIOLOGICS CORPORATION
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 11866477-B22024-01-09
GLP-1 analogues
Sun Pharmaceutical Industries Limited
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 11866488-B22024-01-09
Compositions comprising an anti-metallothionein antibody and a pancreatic cell targeting moiety
UNIVERSITY OF CONNECTICUT and JOSLIN DIABETES CENTER, INC.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3731 of 31 identical, no gaps.
-
KR 1020240004943-A2024-01-11
ERODIBLE TABLET
Eli Lilly and Company
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2024501467-A2024-01-12
NOVEL COMPOUNDS
IP2IPO INNOVATIONS LIMITED
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
US 11873328-B22024-01-16
GLP-1 analogues
Sun Pharmaceutical Industries Limited
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2024503242-A2024-01-25
COMBINATION THERAPY OF INSULINOTROPIC PEPTIDE AND GLP-2, FOR PREVENTING OR TREATING SHORT BOWEL SYNDROME
HANMI PHARM CO LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.
-
JP 2024504134-A2024-01-30
OXYNTOMODULIN BINDING MOLECULES, AND USES THEREOF
Eli Lilly and Company
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3131 of 31 identical, no gaps.